Homebiopharmaceutical

biopharmaceutical

AbbVie’s Botox Could Lose Market Share To Revance New Drug After FDA Approval

AbbVie’s Botox Could Lose Market Share To Revance New Drug After FDA Approval

September 8, 2022

Merck: Four Good Reasons to Take the Green Pill

Merck: Four Good Reasons to Take the Green Pill

September 7, 2022

Pfizer’s Group B Strep Vaccine Gets FDA Breakthrough Designation

September 7, 2022

SpringWorks Increases License Agreement With GSK for Myeloma Combination and Receives $75 Million in Investment

SpringWorks Increases License Agreement With GSK for Myeloma Combination and Receives $75 Million in Investment

September 7, 2022

Pacira Achieves Major Objectives, In a Late-Stage Experiment to Broaden the Indication for Local Anesthetics.

Pacira Achieves Major Objectives, In a Late-Stage Experiment to Broaden the Indication for Local Anesthetics.

September 7, 2022

Roche will pay $250 million upfront to purchase Good Therapeutics in order to expand its immuno-oncology offering

September 7, 2022

Iveric Drives Apellis Lower as Street Responds to Phase 3 Results for the GA Candidate

Iveric Drives Apellis Lower as Street Responds to Phase 3 Results for the GA Candidate

September 6, 2022

Point Biopharma Drops 28% After Phase 3 Data for a Prostate Cancer Candidate

Point Biopharma Drops 28% After Phase 3 Data for a Prostate Cancer Candidate

September 6, 2022

GSK announces an upcoming FDA AdCom conference on the treatment of renal disease

GSK announces an upcoming FDA AdCom conference on the treatment of renal disease

September 6, 2022

Eiger Drops 21% While the Regulatory Pathway for COVID-19 Therapy Is Unknown

Eiger Drops 21% While the Regulatory Pathway for COVID-19 Therapy Is Unknown

September 6, 2022

« 1 … 8 9 10 11 12 … 16 »